SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-010068
Filing Date
2003-03-25
Accepted
2003-03-25 16:06:13
Documents
3
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2106271z10-k.htm 10-K 538135
3 EXHIBIT 10.19 a2106271zex-10_19.htm EX-10.19 12485
4 EXHIBIT 23 a2106271zex-23.htm EX-23 1902
  Complete submission text file 0001047469-03-010068.txt   554332
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 03615858
SIC: 2835 In Vitro & In Vivo Diagnostic Substances